EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells

BACKGROUND: Glioblastomas (GBM) are often characterized by an elevated expression of the epidermal growth factor receptor variant III (EGFRvIII). We used GBM cell lines with native EGFRvIII expression to determine whether this EGFR variant affects radiosensitivity with or without EGFR targeting. MET...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Struve, Nina, Riedel, Matthias, Schulte, Alexander, Rieckmann, Thorsten, Grob, Tobias J., Gal, Andreas, Rothkamm, Kai, Lamszus, Katrin, Petersen, Cordula, Dikomey, Ekkehard, Kriegs, Malte
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2015
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741808/
https://ncbi.nlm.nih.gov/pubmed/26418954
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak